Cough Triggers and Symptoms Among Patients with Refractory or Unexplained Chronic Cough in Two Phase 3 Trials of the P2X3 Receptor Antagonist Gefapixant (COUGH-1 and COUGH-2)

被引：0
|
作者：
Morice, Alyn [1 ]
Birring, Surinder [2 ]
Dicpinigaitis, Peter [3 ]
McGarvey, Lorcan
Pavord, Ian [4 ]
Smith, Jaclyn [5 ]
La Rosa, Carmen [6 ]
Li, Qing [6 ]
Nguyen, Allison Martin [6 ]
Schelfhout, Jonathan [6 ]
Tzontcheva, Anjela [6 ]
Muccino, David [6 ]
机构：
[1] Univ Hull, Kingston Upon Hull, N Humberside, England
[2] Kings Coll London, London, England
[3] Jack D Weiler Hosp, Bronx, NY USA
[4] Univ Oxford, Oxford, England
[5] Univ Manchester, Manchester, Lancs, England
[6] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
188
引用
收藏
页码：AB61 / AB61
页数：1
相关论文
共 50 条
  • [21] Randomised trial of the P2X3 receptor antagonist sivopixant for refractory chronic cough
    Niimi, Akio
    Saito, Junpei
    Kamei, Tadashi
    Shinkai, Masaharu
    Ishihara, Hiroyuki
    Machida, Mitsuaki
    Miyazaki, Sayaka
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (06)
  • [22] The Cough Severity Diary in a pooled analysis of two, phase 3 trials of gefapixant in chronic cough
    Birring, Surinder S.
    Smith, Jaclyn A.
    Morice, Alyn
    Pavord, Ian
    Dicpinigaitis, Peter V.
    Mcgarvey, Lorcan
    Tzontcheva, Anjela
    Li, Qing
    Nguyen, Allison Martin
    Schelfhout, Jonathan
    Muccino, David
    La Rosa, Carmen
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [23] Characterization of chronic cough patients participating in a phase 2b clinical trial of gefapixant, a P2X3 receptor antagonist
    McGarvey, Lorcan
    Smith, Jaclyn
    Birring, Surinder
    Morice, Alyn
    Sher, Mandel
    Wu, Wen-Chi
    Muccino, David
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [24] Burden of Cough in Refractory Chronic Cough Patients Enrolled in A Phase 2b Study of the P2X3 Antagonist BLU-5937
    Goldsobel, Alan
    Blaiss, Michael
    Sher, Mandel
    Birring, Surinder
    Smith, Jaclyn
    Harvey, Laurent
    Yang, Ronghua
    Bonuccelli, Catherine
    Garin, Margaret
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB161 - AB161
  • [25] The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
    Friedrich, Christian
    Francke, Klaus
    Birring, Surinder S.
    van den Berg, Jan Willem K.
    Marsden, Paul A.
    McGarvey, Lorcan
    Turner, Alice M.
    Wielders, Pascal
    Gashaw, Isabella
    Klein, Stefan
    Morice, Alyn H.
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [26] The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
    Christian Friedrich
    Klaus Francke
    Surinder S. Birring
    Jan Willem K. van den Berg
    Paul A. Marsden
    Lorcan McGarvey
    Alice M. Turner
    Pascal Wielders
    Isabella Gashaw
    Stefan Klein
    Alyn H. Morice
    Respiratory Research, 24
  • [27] PATIENT-REPORTED IMPROVEMENTS WITH GEFAPIXANT, A P2X3-RECEPTOR ANTAGONIST, OVER 52 WEEKS IN TWO PHASE 3 CLINICAL TRIALS FOR REFRACTORY OR UNEXPLAINED CHRONIC COUGH
    Birring, S. S.
    Dicpinigaitis, P.
    Morice, A.
    Smith, J. A.
    McGarvey, L.
    Pavord, I.
    Nguyen, A. Martin
    Schelfhout, J.
    Tzontcheva, A.
    Li, Q.
    La Rosa, C.
    Muccino, D.
    THORAX, 2021, 76 : A99 - A99
  • [28] Improvements in cough severity and cough-related quality of life in a phase 2 trial (RELIEF) with the P2X3 antagonist BLU-5937 in refractory chronic cough (RCC)
    Birring, Surinder S.
    Smith, Jaclyn A.
    Morice, Alyn H.
    Sher, Mandel
    Hull, James H.
    Goldsobel, Alan B.
    Lanouette, Sylvain
    Li, Ella
    Harvey, Laurent
    Bonuccelli, Catherine M.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [29] Safety and efficacy of P2X3 antagonist BAY 1902607 in refractory chronic cough
    Friedrich, Christian
    Francke, Klaus
    Birring, Surinder S.
    Van den Berg, J. W. K.
    Marsden, Paul
    Mcgarvey, Lorcan
    Turner, Alice
    Wielders, Pascal
    Gashaw, Isabella
    Klein, Stefan
    Morice, Alyn
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [30] Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC)
    Morice, A. H.
    Smith, J.
    McGarvey, L.
    Birring, S.
    Parker, S. M.
    Turner, A.
    Gashaw, I.
    Fels, L.
    Klein, S.
    Francke, K.
    Friedrich, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345